Three McMaster University students have stepped forward to challenge one of the most persistent and costly hurdles in modern healthcare, aiming to disrupt an industry where high prices have long kept essential devices out of reach for millions of people. Driven by personal experiences watching family members struggle with the financial burden of hearing loss and expensive medical treatments, Arish Shahab, Aaron Yu, and Ramin Syed founded the startup Amano. Their mission is as ambitious as it is straightforward: to engineer and distribute a low-cost, over-the-counter hearing aid expected to cost around twenty dollars a pair.
This breakthrough design offers a dramatically more affordable alternative to standard prescription hearing aids, which frequently command prices in the thousands of dollars. For countless individuals experiencing hearing difficulties, the steep cost of traditional devices acts as an insurmountable wall, forcing them to go without support. The high price tag associated with standard audiological care has created a tiered system where only those with substantial financial resources can afford to protect their hearing health and overall quality of life. By reimagining how these medical devices are manufactured and priced, the student founders hope to democratize access to hearing care, ensuring that financial limitations no longer dictate whether a person can hear clearly.
What sets the Amano device apart from conventional models currently on the market is its radical departure from traditional electronic engineering. Rather than relying on standard digital microprocessors, lithium-ion batteries, miniature microphones, or complex electronic components, the Amano hearing aid utilizes a purely mechanical design. The device operates without any battery power at all, capturing and amplifying sound through precision-engineered vibration. By mimicking the ear’s own natural mechanical function, the startup has bypassed the most expensive components of traditional hearing aids, drastically reducing both production costs and the ongoing maintenance headaches associated with battery replacements and electronic repairs.
In addition to tackling the financial barriers of hearing care, the team behind Amano recognized that cost is only one of the reasons people avoid wearing hearing devices. Social stigma continues to discourage many individuals from seeking the help they need, as traditional hearing aids are often perceived as bulky, medicalized, and conspicuous. To combat this psychological barrier, each pair of Amano hearing aids is custom 3D-printed directly from a photograph of the user’s ear. This personalized manufacturing process ensures an optimal, comfortable fit while styling the devices to resemble modern consumer earbuds. By blending in with the sleek, ubiquitous aesthetic of contemporary personal audio gear, the startup hopes to normalize the appearance of hearing assistance devices and remove the lingering stigma that prevents people from wearing them openly in public.
The journey from a university concept to a viable medical device requires rigorous testing and validation, and Amano is currently navigating these critical early phases. Following initial performance and fit testing conducted on approximately fifty ears, the startup is actively pursuing regulatory and institutional approval to conduct formal clinical studies in partnership with St. Joseph’s Healthcare Hamilton. These upcoming clinical evaluations will provide essential data regarding the efficacy, comfort, and safety of the mechanical design, marking a crucial milestone as the young enterprise transitions from prototype development toward real-world application.
This grassroots innovation arrives against the backdrop of a massive global health challenge that affects communities on a sweeping scale. According to global health estimates, approximately 1.5 billion people worldwide experience some degree of hearing loss. When left unmanaged, hearing impairment is far more than an inconvenience; it can contribute to social isolation, depression, and accelerated cognitive decline, compounding the urgency for accessible interventions. As populations age and the prevalence of hearing loss continues to rise, healthcare systems are under increasing pressure to find scalable, affordable solutions that can reach underserved populations before minor hearing loss escalates into more severe cognitive and social consequences.
The emergence of affordable alternatives like Amano also intersects with evolving regulatory landscapes across Canada, where provincial health authorities are actively evaluating frameworks for over-the-counter hearing aids. Regulatory shifts are already underway, highlighted by British Columbia’s recent approval of non-prescription sales, while Ontario currently engages in consultations regarding similar regulatory models. These policy shifts reflect a broader international trend toward empowering consumers to take greater control of their personal healthcare choices, mirroring regulatory changes in other jurisdictions that have opened the market to direct-to-consumer options.
Healthcare advocates have voiced strong support for expanding access to adult consumers experiencing mild to moderate hearing loss, noting that lower-cost devices can act as an essential entry point into the healthcare continuum. At the same time, medical professionals and industry advocates emphasize the vital need for appropriate regulatory safeguards and baseline hearing assessments. Ensuring that patients undergo proper screening helps guarantee patient safety, rules out underlying medical conditions that require specialized intervention, and ensures that over-the-counter devices are matched appropriately to the user’s specific hearing profile. As regulatory bodies deliberate on how best to integrate these new products into the existing healthcare ecosystem, startups like Amano are helping to reshape the conversation around affordability, accessibility, and innovation in modern medical technology.
